<unk>  is widely used to treat or prevent many infections caused by susceptible bacteria, such as: *urinary tract infections *respiratory tract infections *skin and soft tissue infections *sinus infections *tonsillitis *cat scratches *infections caused by the bacterial flora of the mouth, such as: *dental infections *infected animal bites *infected human bites (including uncomplicated "clenched-fist" or "reverse-bite" injuries) It is also used for tuberculosis that is resistant to other treatments.World health organisation recommends giving<unk> -clavulanate along with meropenem as one of the therapeutic options in drug resistant tuberculosis, where clavulanate and not<unk>  is being relied upon for anti TB activity. However, across the spectrum of dosage of<unk> -clavulanate combination, the dose of clavulanate is constant at 125 mg, whereas the dose of<unk>  varies at 250 mg, 500 mg and 875 mg. Thus the use of low dose<unk> -clavulanate in combination with meropenem may be used in part of treatment regime for drug resistant TB and this has been demonstrated in a clinical setting also. This combination results in an antibiotic with an increased spectrum of action and restored efficacy against<unk> -resistant bacteria that produce β-lactamase.
Amoxicillin/clavulanic acid
Ampicillin/flucloxacillin
Ceftolozane/tazobactam
Piperacillin/tazobactam
Imipenem/cilastatin
Ampicillin/sulbactam
Ceftazidime/avibactam
Cefuroxime axetil